The Impact of Bangladesh Unrest on India's Pharma and Medical Tourism Sector

Bangladesh Unrest: A Challenge for Indian Pharmaceuticals

The recent political unrest in Bangladesh, which began last month with protests demanding the resignation of former Prime Minister Sheikh Hasina, has significantly affected India’s pharmaceutical exports and medical tourism.

Reports indicate that pharmaceutical companies in India are facing challenges including blocked payments and lost consignments, affecting their ability to export to the neighboring country.

Medical Tourism Affected by Political Turmoil

Medical tourism from Bangladesh to India has suffered a severe blow, with many patients cancelling or postponing trips due to the uncertain situation. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has noted that Indian pharma companies are hesitant to ship products to Bangladesh because of unpaid dues.

• Raja Bhanu, Director General of Pharmexcil, highlighted the significant challenges the Indian pharmaceutical industry is facing due to this unrest.
• He stated that shipments are getting stuck at the border, complicating the trade.
• Despite these challenges, there is hope for gradual improvement in the situation.

India accounts for 30 percent of Bangladesh’s pharmaceutical ingredient imports, and the turmoil has led to a noted decline in exports to the country.

Healthcare Providers Facing Uncertainty

As reported by Rajeev Taneja, CEO of Global Care, the decline in patient visits poses a serious concern, with reductions of up to 50 percent reported. This decline directly impacts hospital revenues and highlights increasing uncertainty for patients in need of care.

Fortunately, there may be positive changes ahead, as the Indian visa application center in Bangladesh has started to give out appointments, indicating a potential return to normalcy.